| 138.85 Delayed Data As of May 24 |  +0.01 / +0.01%Today’s Change | 118.62 Today|||52-Week Range 148.99 | +7.59% Year-to-Date |
| Previous close | 138.84 |
| Today’s open | 139.50 |
| Day’s range | 138.56 - 139.50 |
| Volume | 5,473,499 |
| Average volume (3 months) | 6,539,067 |
| Market cap | $368.7B |
| Earnings growth (last year) | +1,087.50% |
| Earnings growth (this year) | +5.29% |
| Earnings growth (next 5 years) | +5.73% |
| Revenue growth (last year) | +6.61% |
| P/E ratio | 25.7 |
| Price/Sales | 4.26 |
| Price/Book | 6.19 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.03 | +0.07% |
| MRKMerck | +0.15 | +0.19% |
| NVSNovartis | +3.08 | +3.65% |
| ABTAbbott Laboratories | +1.35 | +1.79% |
| Next reporting date | July 16, 2019 |
| EPS forecast (this quarter) | $2.43 |
| Annual revenue (last year) | $81.5B |
| Annual profit (last year) | $15.3B |
| Net profit margin | 18.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Alex Gorsky |
Chief Financial Officer & Executive Vice President Joseph J. Wolk |
Corporate headquarters New Brunswick, New Jersey |
